BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24752339)

  • 1. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses.
    Cheng X; Sun P; Hu QG; Song ZF; Xiong J; Zheng QC
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1159-70. PubMed ID: 24752339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
    Oliveri RS; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2011 Mar; (3):CD004787. PubMed ID: 21412886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails.
    Wang G; Zhang J; Liu H; Zheng Q; Sun P
    BMC Gastroenterol; 2024 Jun; 24(1):195. PubMed ID: 38849765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review.
    Xie ZB; Ma L; Wang XB; Bai T; Ye JZ; Zhong JH; Li LQ
    Tumour Biol; 2014 Sep; 35(9):8451-9. PubMed ID: 25038916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
    HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.
    Piardi T; Memeo R; Renard Y; Ammendola M; Bruno O; Habersetzer F; Baumert T; Pessaux P; Sommacale D
    Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials.
    Si T; Chen Y; Ma D; Gong X; Yang K; Guan R; Peng C
    Scand J Gastroenterol; 2016 Dec; 51(12):1512-1519. PubMed ID: 27598831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
    PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.
    Wang Z; Ren Z; Chen Y; Hu J; Yang G; Yu L; Yang X; Huang A; Zhang X; Zhou S; Sun H; Wang Y; Ge N; Xu X; Tang Z; Lau W; Fan J; Wang J; Zhou J
    Clin Cancer Res; 2018 May; 24(9):2074-2081. PubMed ID: 29420221
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).
    Comito T; Loi M; Franzese C; Clerici E; Franceschini D; Badalamenti M; Teriaca MA; Rimassa L; Pedicini V; Poretti D; Solbiati LA; Torzilli G; Ceriani R; Lleo A; Aghemo A; Santoro A; Scorsetti M
    Curr Oncol; 2022 Nov; 29(11):8802-8813. PubMed ID: 36421345
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.
    Chua TC; Liauw W; Saxena A; Chu F; Glenn D; Chai A; Morris DL
    Liver Int; 2010 Feb; 30(2):166-74. PubMed ID: 19912531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.